| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 12/24/2013 | US8614210 Process for preparing pharmaceutical ophthalmic compositions |
| 12/24/2013 | US8614209 Amido-thiophene compounds and their use |
| 12/24/2013 | US8614208 Fused heterocyclic ring derivative and use thereof |
| 12/24/2013 | US8614207 Inhibitors of hepatitis C virus |
| 12/24/2013 | US8614206 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use |
| 12/24/2013 | US8614205 Glutamate receptor modulators and therapeutic agents |
| 12/24/2013 | US8614204 Enhanced erythropoiesis and iron metabolism |
| 12/24/2013 | US8614203 Methods for the treatment of a central nervous system injury via a tapered administration protocol |
| 12/24/2013 | US8614202 2α-methyl and 2β-methyl analogs of 19,26,27-trinor-(20S)-1α-hydroxyvitamin D3 and their uses |
| 12/24/2013 | US8614201 Heterocyclic amides as modulators of TRPA1 |
| 12/24/2013 | US8614200 Compounds, compositions and methods for treating ocular conditions |
| 12/24/2013 | US8614199 Compositions comprising at least one complex composed of a derivative of naphthoic acid and of at least one cyclodextrin and uses thereof |
| 12/24/2013 | US8614197 Anti-tumor compounds with angeloyl groups |
| 12/24/2013 | US8614196 Treatment and/or prevention of inflammation and cutaneous photodamage and photoprotection of the skin with a water-soluble extract from plant of Solanum genus |
| 12/24/2013 | US8614195 Glycoside derivatives and uses thereof |
| 12/24/2013 | US8614193 Depsipeptides and their therapeutic use |
| 12/24/2013 | US8614192 Method for treating ocular cancer |
| 12/24/2013 | US8614190 Thermal responsive composition for treating bone diseases |
| 12/24/2013 | US8614184 HCG formulations for achieving weight loss |
| 12/24/2013 | US8614168 Use of azoles for increasing the abiotic stress resistance of plants or plant parts |
| 12/24/2013 | US8613960 Formulations and methods for reducing waist circumference |
| 12/24/2013 | US8613956 Cosmetic particles that transform from hard to soft particles comprising hydrogenated long-chain triglyceride oils |
| 12/24/2013 | US8613954 Drug loaded polymeric nanoparticles and methods of making and using same |
| 12/24/2013 | US8613951 Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same |
| 12/24/2013 | US8613950 Pharmaceutical forms with improved pharmacokinetic properties |
| 12/24/2013 | US8613948 Treatment of faecal incontinence and other conditions with 1R, 2S-methoxamine |
| 12/24/2013 | US8613947 Bromocriptine formulations |
| 12/24/2013 | US8613946 Carotenoids of enhanced bioavailability |
| 12/24/2013 | US8613945 Stable pharmaceutical composition and methods of using same |
| 12/24/2013 | US8613944 Compositions and methods for separating tissue |
| 12/24/2013 | US8613940 Carbonate derivatives as skin care |
| 12/24/2013 | US8613929 Methods and compositions for targeting agents into and across the blood-brain barrier and other endothelial cell microvascular barriers |
| 12/24/2013 | US8613912 Silicone organo polyesters |
| 12/24/2013 | US8613909 Cinnamic acid-based oligomers and uses thereof |
| 12/24/2013 | DE102012012263A1 Verfahren zur Herstellung von Polyquaternium-1 Process for the preparation of Polyquaternium-1 |
| 12/24/2013 | CA2783175C Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives |
| 12/24/2013 | CA2759936C Oral compositions for skin benefits |
| 12/24/2013 | CA2714181C Ampk modulators |
| 12/24/2013 | CA2706512C Compositions and devices |
| 12/24/2013 | CA2706486C Oral care product and methods of use and manufacture thereof |
| 12/24/2013 | CA2662565C Process for the preparation of an (rp)-8-substituted camps |
| 12/24/2013 | CA2660383C Pharmacologically active disulfide compounds |
| 12/24/2013 | CA2654281C Use of phytate as agent inhibiting dissolution of crystals of calcium salts for the prevention of osteoporosis |
| 12/24/2013 | CA2644035C Process for producing a solid dispersion of an active ingredient |
| 12/24/2013 | CA2641546C Therapeutic agent for inflammatory bowel disease containing as active ingredient 2-amino-1,3-propanediol derivative, or method for treating inflammatory bowel disease |
| 12/24/2013 | CA2626134C Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
| 12/24/2013 | CA2625642C Prolinamide derivatives as sodium channel modulators |
| 12/24/2013 | CA2625055C Novel dihydropseudoerythromycin derivatives |
| 12/24/2013 | CA2623731C Vitamin d derivatives active on the vitamin d nuclear receptor, preparation and uses thereof |
| 12/24/2013 | CA2621577C Methods and compositions for oral administration of proteins |
| 12/24/2013 | CA2620472C Substituted benzimidazoles as kinase inhibitors |
| 12/24/2013 | CA2617096C Macrocyclic inhibitors of hepatitis c virus |
| 12/24/2013 | CA2616954C Macrocyclic inhibitors of hepatitis c virus |
| 12/24/2013 | CA2613059C Substituted glycinamides having an antithrombotic and factor xa-inhibiting effect, process for their manufacture and use thereof as medicaments |
| 12/24/2013 | CA2611450C Method for producing polymerized coordination compounds of platinum complex |
| 12/24/2013 | CA2605510C Inhibitors of microsomal triglyceride transfer protein and apo-b secretion |
| 12/24/2013 | CA2602787C Pyridine-3-carboxamide derivatives as cb1 inverse agonists |
| 12/24/2013 | CA2600606C Indanes |
| 12/24/2013 | CA2597608C Pyrazolo-pyrimidine derivatives as mglur2 antagonists |
| 12/24/2013 | CA2585337C Trisubstituted thiophenes as progesterone receptor modulators |
| 12/24/2013 | CA2583756C Pharmaceutical composition comprising microcapusles of statins suspended in alkyl esters of polyunsaturated fatty acids (pufa) |
| 12/24/2013 | CA2576781C Phosphole derivatives complexed with metals, and pharmaceutical uses thereof |
| 12/24/2013 | CA2575787C Dihydropteridinones for the treatment of cancer diseases |
| 12/24/2013 | CA2567821C Quinazolinone derivatives useful as vanilloid antagonists |
| 12/24/2013 | CA2565200C Raf modulators and methods of use |
| 12/24/2013 | CA2561146C 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1h-1,2,4-triazol-1-yl)-1h-pyrrolo[2-,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine for use in treating hiv infection |
| 12/24/2013 | CA2560047C Substituted imidazoles and their use as opioid receptor modulators |
| 12/24/2013 | CA2554082C Use of epothilones in the treatment of neuronal connectivity defects such as schizophrenia and autism |
| 12/24/2013 | CA2553248C Treatment of cancer using benzoic acid derivatives |
| 12/24/2013 | CA2500822C Nodulisporic acid derivative spot-on formulations for combating parasites |
| 12/24/2013 | CA2487915C Allergen from mugwort pollen |
| 12/24/2013 | CA2485988C Methods of modulating tubulin deacetylase activity |
| 12/19/2013 | WO2013188887A1 Suppression of sars replication by sars helicase inhibitors |
| 12/19/2013 | WO2013188882A1 Macromolecules for treating atherosclerosis |
| 12/19/2013 | WO2013188881A1 Compounds, compositions and methods for treating or preventing neurodegenerative disorders |
| 12/19/2013 | WO2013188877A1 The use of compounds elevating glutathione levels for the treatment of parkinson's disease |
| 12/19/2013 | WO2013188856A1 Imidazopyrazine syk inhibitors |
| 12/19/2013 | WO2013188848A2 Antiviral compounds and methods of use |
| 12/19/2013 | WO2013188847A1 Compositions and methods for transmucosal absorption |
| 12/19/2013 | WO2013188838A2 Storage, retrieval, analysis, pricing, and marketing of personal health care data using social networks, expert networks, and markets |
| 12/19/2013 | WO2013188829A1 Desfesoterodine salts |
| 12/19/2013 | WO2013188818A1 A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof |
| 12/19/2013 | WO2013188813A2 Novel therapeutics for brain cancer |
| 12/19/2013 | WO2013188786A1 Compositions and methods for treating airway inflammatory diseases |
| 12/19/2013 | WO2013188783A1 Deuterated derivatives of ruxolitinib |
| 12/19/2013 | WO2013188767A1 Method and system for measuring the pharmacokinetics of liposomal curcumin and its metabolite tetrahydrocurcumin |
| 12/19/2013 | WO2013188763A1 Compositions for treating cancer and methods for making the same |
| 12/19/2013 | WO2013188750A2 Substituted macrocyclic compounds having proteasome inhibitory activity |
| 12/19/2013 | WO2013188737A2 Methods for improved delivery of aminothiols, dimers of aminothiols, and heterodimers composed of aminothiols |
| 12/19/2013 | WO2013188727A2 Novel pro- and codrug derivatives for nanoparticle delivery of select anticancer agents formed using rapidly cleavable phenolic ester bridges |
| 12/19/2013 | WO2013188724A1 Azetidine and piperidine compounds useful as pde10 inhibitors |
| 12/19/2013 | WO2013188586A1 Methods for treating pancreatic cancer using combination therapies comprising liposomal irinotecan |
| 12/19/2013 | WO2013188509A1 Seizure therapy |
| 12/19/2013 | WO2013188465A2 Pharmaceutical compositions and methods for treating drug addiction and preventing a drug relapse |
| 12/19/2013 | WO2013188452A1 Compounds and methods of treating cancer |
| 12/19/2013 | WO2013188417A2 Treatment and prevention of cardiovascular disease and thrombosis |
| 12/19/2013 | WO2013188396A1 Combination of therapeutic agents for treating hcv infection |
| 12/19/2013 | WO2013188355A1 Cdk inhibitor for treating refractory chronic lymphocytic leukemia |
| 12/19/2013 | WO2013188314A1 Compounds for treating inflammation and pain |
| 12/19/2013 | WO2013188283A1 Topical ophthalmological pharmaceutical composition containing sunitinib |